PharmaEngine Inc logo — A Taiwan-Based New Drug Development Company

PharmaEngine Inc

A Taiwan-Based New Drug Development Company

Founded 2003 Taiwan Taiwan 27 employees Biotechnology

General Information

Company Name PharmaEngine Inc
Founded Year 2003
Location Taiwan Taiwan +1
Employees 27
Industries Biotechnology
Social

Get notified when PharmaEngine Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PharmaEngine Inc

PharmaEngine Inc is a Taiwan-based biotechnology company that has been in operation since 2003, listed on the Taipei Exchange with the stock code 4162.TWO. The company is dedicated to developing drugs for cancer patients, with a strong focus on precision oncology related to DNA damage response (DDR) pathways. Their lead candidate, PEP07, is an orally bioavailable small molecule CHK1 inhibitor currently in Phase 1 clinical studies for Acute Myeloid Leukemia (AML), Mantle Cell Lymphoma (MCL), or advanced/metastatic solid tumors. In the past, PharmaEngine successfully developed and out-licensed its first commercial product, ONIVYDE, for the treatment of metastatic pancreatic adenocarcinoma. PharmaEngine's preclinical pipeline includes other targets in the DDR pathways aiming to provide synergy when in combination with chemo/radiation therapies or with other precision oncology medicines. The company emphasizes a sustainable business and work environment with six core values, including "Sense of Urgency," "Critical Thinking," "Diversity," "Continuous Learning and Growth," "Teamwork," and "Work and Life Balance." PharmaEngine's commitment to employee welfare and inclusivity is evident in their values, as they encourage diversity, continuous learning, teamwork, and work-life balance. Their dedication to developing innovative treatments for cancer patients, as well as their emphasis on a supportive work environment, positions them as a compelling investment opportunity in the biotechnology industry. For more information, please visit PharmaEngine's company website.

Taxonomy: pharmaceuticals, oncology, precision medicine, drug development, clinical trials, cancer treatment, CHK1 inhibitor, DNA damage response pathways, commercialization, pancreatic cancer, metastatic cancer, nanoparticle, radio-enhancer, work environment

No funding data available for PharmaEngine Inc yet.

Get notified when PharmaEngine Inc raises funding

PharmaEngine Inc Alternatives & Competitors

PharmaEngine Inc vs
AVEO Oncology
AVEO Oncology United States

Committed to delivering medicines that provide a better life for patients with cancer.

Post Ipo Equity
197 employees
Biotechnology, Health Care
PharmaEngine Inc vs
Blueprint Medicines
Blueprint Medicines United States

Striving to improve and extend patients' lives

Acquired
782 employees
Biotechnology, Health Care
PharmaEngine Inc vs
Clovis Oncology
Clovis Oncology United States

Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a commer...

Series Unknown
70 employees
Biopharma

FAQ About PharmaEngine Inc

A Taiwan-Based New Drug Development Company
PharmaEngine Inc was founded in 2003.
PharmaEngine Inc is headquartered in Taiwan.
PharmaEngine Inc operates in the following industries: Biotechnology.
PharmaEngine Inc has approximately 27 employees.
Top alternatives and competitors to PharmaEngine Inc include AVEO Oncology, Blueprint Medicines, Clovis Oncology, Anticancer Bioscience, Strata Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmaEngine Inc and AVEO Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PharmaEngine Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy